Article
Whole-genome sequencing identifies MprF mutations in a genetically diverse population of daptomycin non-susceptible Staphylococcus aureus in Australia.
International journal of antimicrobial agents - 1 May 2024
Lim Candice, Coombs Geoffrey W, Daley Denise A, Shoby Princy, Mowlaboccus Shakeel
Abstract excerpt
OBJECTIVES: Daptomycin is one of the few last-line antimicrobials available for the treatment of multidrug-resistant Staphylococcus aureus infections. An increasing number of daptomycin non-susceptible S. aureus infections has been reported worldwide, including Australia. Resistance to daptomycin is multifactorial and involves chromosomal mutations in genes encoding proteins involved in cell membrane and cell...
Topics
Join the communities discussing this publication.
